Cargando…
Benzylideneacetophenone derivatives attenuate IFN-γ-induced IP-10/CXCL10 production in orbital fibroblasts of patients with thyroid-associated ophthalmopathy through STAT-1 inhibition
The aim of the present study was to identify a new candidate anti-inflammatory compound for use in the active stage of thyroid-associated ophthalmopathy (TAO). Benzylideneacetophenone compound JC3 [(2E)-3-(4-hydroxy-3-methoxyphenyl)phenylpro-2-en-l-one] was synthesized based on a structural modifica...
Autores principales: | Lee, Sung-Hee, Lim, Seul Ye, Choi, Ji Ha, Jung, Jae-Chul, Oh, Seikwan, Kook, Koung Hoon, Choi, Youn-Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081550/ https://www.ncbi.nlm.nih.gov/pubmed/24924312 http://dx.doi.org/10.1038/emm.2014.26 |
Ejemplares similares
-
SLC/CCL21-mediated anti-tumor responses require IFNγ, MIG/CXCL9 and IP-10/CXCL10
por: Sharma, Sherven, et al.
Publicado: (2003) -
Dipyrithione inhibits IFN-γ-induced JAK/STAT1 signaling pathway activation and IP-10/CXCL10 expression in RAW264.7 cells
por: Han, Cui, et al.
Publicado: (2010) -
Benzylideneacetophenone Derivative Alleviates Arthritic Symptoms via Modulation of the MAPK Signaling Pathway
por: Sur, Bongjun, et al.
Publicado: (2020) -
JC2-11, a benzylideneacetophenone derivative, attenuates inflammasome activation
por: Lee, Gilyoung, et al.
Publicado: (2022) -
An IP-10 (CXCL10)-Derived Peptide Inhibits Angiogenesis
por: Yates-Binder, Cecelia C., et al.
Publicado: (2012)